Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q1 2018 · 10-Q
Revenue$364.00K$364.00K+691.0% vs Q1 2017 Net Income-$2.43M-$2.43MN/M vs Q1 2017 EPS Diluted-$0.02-$0.02N/M vs Q1 2017 Gross Profit$100,000+325.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flow-$996,000N/M Free Cash Flowderived-$1,014,753— Margins · derivedGross margin27.5%−23.6 pt vs Q1 2017
Operating margin-440.1%+2669.2 pt vs Q1 2017
Net margin-667.6%+4386.4 pt vs Q1 2017
ended Mar 31, 2018 · filed May 14, 2018 · 44 d after period end